ES458689A1 - Procedimiento de preparacion de nuevos derivados del ditiol-1,2. - Google Patents

Procedimiento de preparacion de nuevos derivados del ditiol-1,2.

Info

Publication number
ES458689A1
ES458689A1 ES458689A ES458689A ES458689A1 ES 458689 A1 ES458689 A1 ES 458689A1 ES 458689 A ES458689 A ES 458689A ES 458689 A ES458689 A ES 458689A ES 458689 A1 ES458689 A1 ES 458689A1
Authority
ES
Spain
Prior art keywords
carbon atoms
part contains
alkyl part
whose alkyl
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES458689A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Industries SA
Original Assignee
Rhone Poulenc Industries SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7603604A external-priority patent/FR2340730A1/fr
Priority claimed from FR7638901A external-priority patent/FR2374906A2/fr
Application filed by Rhone Poulenc Industries SA filed Critical Rhone Poulenc Industries SA
Publication of ES458689A1 publication Critical patent/ES458689A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Procedimiento de preparación de nuevos derivados del ditiol-1,2, de fórmula general: *** ver imagen 01 en la que: Het representa un radical heterocíclico aromático de 6 anillos que contiene 2 átomos de nitrógeno o por un radical alquilo que contiene de 1 a 4 átomos de carbono, alquiloxilo cuya parte alquilo contiene 1 a 4 átomos de carbono, mercapto, alquiltio, cuya parte alquilo contiene 1 a 4 átomos de carbono, pirrolidino, piperidino, morfolino, o N-alquilpiperacinil-1 cuya parte alquilo contiene 1 a 4 átomos de carbono y R representa un radical alquiloxicarbonilo cuya parte alquilo contiene 1 a 4 átomos de carbono caracterizado porque se esterifica un producto de fórmula general: *** ver imagen 02 en la que Het se define como anteriormente.
ES458689A 1976-02-10 1977-05-11 Procedimiento de preparacion de nuevos derivados del ditiol-1,2. Expired ES458689A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7603604A FR2340730A1 (fr) 1976-02-10 1976-02-10 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent
FR7638901A FR2374906A2 (fr) 1976-12-23 1976-12-23 Nouveaux derives du dithiole-1,2, leur preparation et les compositions qui les contiennent

Publications (1)

Publication Number Publication Date
ES458689A1 true ES458689A1 (es) 1978-07-16

Family

ID=26219294

Family Applications (3)

Application Number Title Priority Date Filing Date
ES455790A Expired ES455790A1 (es) 1976-02-10 1977-02-10 Procedimiento de preparacion de nuevos derivados del di- tiol-1,2.
ES458688A Expired ES458688A1 (es) 1976-02-10 1977-05-11 Procedimiento de preparacion de nuevos derivados del ditiol-1,2.
ES458689A Expired ES458689A1 (es) 1976-02-10 1977-05-11 Procedimiento de preparacion de nuevos derivados del ditiol-1,2.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES455790A Expired ES455790A1 (es) 1976-02-10 1977-02-10 Procedimiento de preparacion de nuevos derivados del di- tiol-1,2.
ES458688A Expired ES458688A1 (es) 1976-02-10 1977-05-11 Procedimiento de preparacion de nuevos derivados del ditiol-1,2.

Country Status (26)

Country Link
US (1) US4110450A (es)
JP (1) JPS5822119B2 (es)
AR (1) AR224095A1 (es)
AT (1) AT348535B (es)
AU (1) AU509092B2 (es)
CA (1) CA1073906A (es)
CH (2) CH618699A5 (es)
DE (1) DE2705641C3 (es)
DK (1) DK55477A (es)
EG (1) EG13739A (es)
ES (3) ES455790A1 (es)
GB (1) GB1518071A (es)
HK (1) HK17481A (es)
HU (1) HU172528B (es)
IE (1) IE44561B1 (es)
IL (1) IL51403A (es)
KE (1) KE3126A (es)
LU (1) LU76728A1 (es)
MY (1) MY8200001A (es)
NL (1) NL171985C (es)
OA (1) OA05565A (es)
PH (1) PH12367A (es)
PT (1) PT66175B (es)
SE (1) SE427274B (es)
SU (1) SU683622A3 (es)
ZM (1) ZM1477A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001125A (en) 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
EE04588B1 (et) * 1997-10-27 2006-02-15 Neurosearch A/S Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
JP2004515453A (ja) 2000-05-05 2004-05-27 ウィスコンシン・アルムナイ・リサーチ・ファウンデーション 癌を化学療法および放射線療法に付する間に細胞を保護するための組成物および方法
KR100491318B1 (ko) * 2002-11-26 2005-05-24 씨제이 주식회사 올티프라즈(Ｏｌｔｉｐｒａｚ) 제조방법
MX2007003332A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de estearoil-coa-desaturasa.
BRPI0515500A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados piridazina para inibição de estearoil-coa-desaturase
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
BRPI0515482A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seus usos como agentes terapêuticos
CN101084211A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为治疗剂的用途
AU2005286647A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
CA2618646A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
US7910600B2 (en) * 2007-08-31 2011-03-22 Cylene Pharmaceuticals, Inc. Therapeutic kinase modulators
WO2016207914A2 (en) * 2015-06-25 2016-12-29 St Ip Holding Ag Methods for preparing oltipraz
US20160376259A1 (en) * 2015-06-25 2016-12-29 St Ip Holding Ag Methods for Preparing Oltipraz
WO2018047002A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
WO2018047013A1 (en) 2016-09-12 2018-03-15 St Ip Holding Ag Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
WO2019171174A2 (en) 2018-03-07 2019-09-12 St Ip Holding Ag Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same
US11135220B1 (en) 2020-04-08 2021-10-05 St Ip Holding Ag Methods of treating viral infections with formulated compositions comprising 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1526768A (fr) 1963-01-16 1968-05-31 Procédé de préparation de dérivés sulfoniques de dithiole-1, 2 thiones-3 diversement substituées, et applications des produits ainsi obtenus

Also Published As

Publication number Publication date
DE2705641C3 (de) 1981-01-22
ATA90277A (de) 1978-07-15
OA05565A (fr) 1981-04-30
DK55477A (da) 1977-08-11
PH12367A (en) 1979-01-29
PT66175A (fr) 1977-03-01
US4110450A (en) 1978-08-29
IE44561B1 (en) 1982-01-13
JPS5822119B2 (ja) 1983-05-06
CA1073906A (fr) 1980-03-18
ES458688A1 (es) 1978-07-16
IL51403A0 (en) 1977-04-29
DE2705641A1 (de) 1977-08-11
IL51403A (en) 1980-09-16
JPS52113982A (en) 1977-09-24
MY8200001A (en) 1982-12-31
SE7701460L (sv) 1977-08-11
AR224095A1 (es) 1981-10-30
ZM1477A1 (en) 1977-12-21
AU509092B2 (en) 1980-04-17
AT348535B (de) 1979-02-26
PT66175B (fr) 1978-07-10
HU172528B (hu) 1978-09-28
CH618699A5 (es) 1980-08-15
LU76728A1 (es) 1977-08-18
HK17481A (en) 1981-05-08
GB1518071A (en) 1978-07-19
AU2213877A (en) 1978-08-17
SE427274B (sv) 1983-03-21
DE2705641B2 (de) 1980-05-08
SU683622A3 (ru) 1979-08-30
CH619463A5 (es) 1980-09-30
NL171985C (nl) 1983-06-16
NL7701107A (nl) 1977-08-12
EG13739A (en) 1983-03-31
KE3126A (en) 1981-05-29
ES455790A1 (es) 1978-01-16
IE44561L (en) 1977-08-10

Similar Documents

Publication Publication Date Title
ES458689A1 (es) Procedimiento de preparacion de nuevos derivados del ditiol-1,2.
ES426303A1 (es) Procedimiento para la obtencion de derivados de oxazolidi- na.
ES311444A1 (es) Procedimiento para la obtencion de compuestos piridinicos.
ES462304A1 (es) Un procedimiento para la preparacion de nuevos derivados de urazol 1,2,4-sustituidos.
ES470784A1 (es) Procedimiento para la preparacion de aminoalcoxibenzofuranos
ES409461A1 (es) Procedimiento para la obtencion de derivados de la amida del acido lisergico.
ES395766A1 (es) Procedimiento para la obtencion de derivados de la hidan- toina.
ES440438A1 (es) Procedimiento para la preparacion de nuevos derivados de fe-nilbutazona.
ES265288A1 (es) Procedimiento para la preparaciën de nuevos 1,3,4-tiadiazoles
ES451466A1 (es) Procedimiento para la preparacion de nuevos derivados de 5- tiazol-metanoamina.
ES414056A1 (es) Procedimiento para preparar esteres del acido acetilsalici-lico.
ES458687A1 (es) Procedimiento de preparacion de nuevos derivado del ditiol -1,2.
ES270019A1 (es) Procedimiento de obtenciën de nuevos compuestos 2,3-dihidro de la serie de los acidos lisergico y dihidrolisergico
ES474461A1 (es) Procedimiento de obtencion de amidas desoxivincaminicas.
ES458205A1 (es) Procedimiento para la produccion de 2-feniliminotiazolinas sustituidas.
ES389044A1 (es) Procedimiento para la obtencion de derivados del benzoci- cloheptatiofeno.
ES445922A1 (es) Procedimiento para preparar derivados de benzofuranona.
ES413044A1 (es) Procedimiento de preparacion de fenotiazinas.
ES456351A1 (es) Procedimiento para preparar esteres o,s-dialquil-o-pirazoli-cos de acido ditiofosforico.
ES471741A1 (es) Procedimiento para la obtencion de derivados de perhidro-aza-heterociclos
ES477742A3 (es) Un procedimiento para preparar tetrahidronaftiloxiaminopro- panoles.
ES416663A1 (es) Metodo de obtencion de nuevos derivados de las isoteofili- nas.
ES460516A3 (es) Procedimiento para la obtencion de isotioureas.
ES334197A1 (es) Procedimiento para preparar derivados de 9-10-dihidro-4h- benzo (4,5) ciclohepta (2,1-b) tiofeno.
ES307320A2 (es) Procedimiento para la produccion de compuestos heterociclicos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990601